Concepedia

Endogenous platelet-activating factor and anti-platelet-activating factor in patients with renovascular hypertension

Fuminori Masugi, Toshio Ogihara, Shuichi Saeki, Katsuhiko Sakaguchi, Y Kumahara, Kiyoshi Satouchi, Makoto Oda, Kunihiko Saito, Koh Tokunaga

Life Sciences · 1988 · 14 citations · 10 references

DOI

Concepts

References

10

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

E. G. Bligh, W. J. Dyer · Canadian Journal of Biochemistry and Physiology · 1959 · 48.9K citations

, , +9

Antihypertensive activity of an alkyl ether analog of phosphatidylcholine

Merle L. Blank, Fred Snyder, Lawrence W. Byers et al. · Biochemical and Biophysical Research Communications · 1979 · 559 citations

, , +9

TREATMENT OF RENOVASCULAR HYPERTENSION WITH PERCUTANEOUS TRANSLUMINAL DILATATION OF A RENAL-ARTERY STENOSIS

A Grüntzig, W. Vetter, Bernhard Meier et al. · The Lancet · 1978 · 492 citations

, , +12

Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine.

D J Hanahan, Constantinos A. Demopoulos, Joachim G. Liehr et al. · Journal of Biological Chemistry · 1980 · 409 citations · Full text

, , +13

Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

Linda M. McManus, D J Hanahan, Constantinos A. Demopoulos et al. · The Journal of Immunology · 1980 · 263 citations

, , +8